Wednesday, June 3, 2020

Gilead#39;s remdesivir could see $7 billion in annual sales on stockpiling boost: Analyst

Gilead#39;s remdesivir could see $7 billion in annual sales on stockpiling boost: Analyst The US drugmaker is yet to set a price for the drug that is currently being administered intravenously in hospitals.

from Moneycontrol Business News https://ift.tt/2U7W6rX

No comments:

Post a Comment

Good news for Indian mutual fund investors: SpaceX could join Nasdaq 100 after 15 trading days

SpaceX’s expected entry into the Nasdaq-100 could give Indian investors indirect exposure through Nasdaq-linked mutual funds. Jefferies says...